Table 7 Screening efficiency of FAIE system for comorbid asthma in CRSwNP patients in the validation group
FAIE score | ≥ 0 | ≥ 1 | ≥ 2 | ≥ 3 | ≥ 4 | ≥ 5 | ≥ 6 |
|---|---|---|---|---|---|---|---|
Sensitivity (%) | 100.0 | 100.0 | 98.8 | 76.9 | 48.7 | 35.9 | 20.5 |
Specificity (%) | 0.0 | 27.8 | 40.3 | 74.4 | 94.9 | 94.9 | 97.4 |
Positive predictive value (%) | 52.6 | 60.6 | 64.8 | 75.0 | 90.5 | 87.5 | 88.9 |
Negative predictive value (%) | 0.0 | 100.0 | 96.7 | 76.3 | 64.9 | 59.7 | 55.1 |
Youden Index | 0.0 | 0.278 | 0.391 | 0.513 | 0.436 | 0.308 | 0.179 |
Prevalence of asthma (%) | 52.6 | 60.6 | 64.8 | 75.0 | 90.5 | 87.5 | 88.9 |